"The patient is speaking": Discovering the patient voice in ophthalmology

British Journal of Ophthalmology

Volumn 101, Issue 6, 2017, Pages 700-708

  Dean, Samera ^a   Mathers, Jonathan M ^b   Calvert, Melanie ^b   Kyte, Derek G ^b   Conroy, Dolores ^c   Folkard, Annie ^d   Southworth, Sue ^e   Murray, Philip I ^b,f   Denniston, Alastair K ^b,e,g,h  

^a West Midlands Strategic Health Authority   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Fight for Sight Charity   (United Kingdom)

^d Birdshot Uveitis Society   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f CITY HOSPITAL   (United Kingdom)

^g Birmingham Women's Hospital NHS Foundation Trust   (United Kingdom)

^h MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

medical; Public health; treatment; Vision

Indexed keywords

RANIBIZUMAB;

AGE RELATED MACULAR DEGENERATION; EYE DISEASE; GLAUCOMA; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATIENT ADVOCACY; PATIENT-REPORTED OUTCOME; PEER GROUP; PRIORITY JOURNAL; PUBLIC HEALTH CAMPAIGN; QUALITATIVE RESEARCH; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RESEARCH PRIORITY; REVIEW; SHARED DECISION MAKING; VISUAL IMPAIRMENT; DOCTOR PATIENT RELATION; OPHTHALMOLOGY; OUTCOME ASSESSMENT;

HUMANS; OPHTHALMOLOGY; PATIENT OUTCOME ASSESSMENT; PHYSICIAN-PATIENT RELATIONS; QUALITATIVE RESEARCH;

EID: 85020134920     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2016-309955     Document Type: Review

References (87)

1. Health Foundation. Person centred care made simple. www. health. org. uk/publications/person- centred- care- made- simple (accessed 16 Oct 2016)
2. Richards T, Coulter A, Wicks P. Time to deliver patient centred care. BMJ 2015;350:h530
3. Foot C, Gilburt H, Dunn P, et al. People in control of their own health and care. Kings Fund 2014 https://www. kingsfund. org. uk/publications/people- control- their- ownhealth- and- care (accessed 27 Oct 2016)
4. Fahey T, NicLiam B. Assembling the evidence for patient centred care. BMJ 2014;349:g4855
5. Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2014;28:CD001431
6. Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient reported outcomes during routine cancer treatment: a randomised controlled trial. J Clin Oncol 2016;34:557-65
7. Velikova G, Booth L, Smith AB, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 2004;22:714-24
8. Detmar SB, Muller MJ, Schornagel JH, et al. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. Jama 2002;288:3027-34
9. Snyder CF, Aaronson NK, Choucair AK, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res 2012;21:1305-14
10. Basch E. Patient-reported outcomes - Harnessing patients' Voices to improve clinical care. N Engl J Med 2017;376:105-8
11. Equity and excellence: liberating the NHS. https://www. gov. uk/government/uploads/system/uploads/attachment- data/file/213823/dh- 117794. pdf (accessed 5 Oct 2016)
12. HR3590. patient protection and affordable care act. https://www. congress. gov/bill/111th- congress/house- bill/3590 (accessed 16 Oct 2016)
13. Patient knows best. http://www. patientsknowbest. com/(accessed 5 Oct 2016)
14. Research design service (RDS) Patient and public involvement (PPI) handbook. www. nihr. ac. uk/funding /how-we-can-help-you/RDS- PPI- Handbook- 2014- v8- FINAL. pdf (accessed 16 Oct 2016)
15. Holloway I, Wheeler S. Qualitative research in nursing and healthcare. London, UK: Wiley-Blackwell, 2015:1-368
16. Green G, Thorogood N. Qualitative methods for health research. London, UK: SAGE Publications, 2014:1-360
17. Thorne S. Interpretive description. London, UK: Routledge, 2008:1-272
18. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101
19. Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol 2009;9:59
20. Seale C. The quality of qualitative research. London, UK: SAGE Publications, 1999:1-224
21. Green J, Siddall H, Murdoch I. Learning to live with Glaucoma: a qualitative study of diagnosis and the impact of sight loss. Soc Sci Med 2002;55:257-67
22. Glen FC, Crabb DP. Living with Glaucoma: a qualitative study of functional implications and patients' coping behaviours. BMC Ophthalmol 2015;15:128
23. Crabb DP, Smith ND, Glen FC, et al. How does Glaucoma look?: patient perception of visual field loss. Ophthalmology 2013;120:1120-6
24. Glen FC, Baker H, Crabb DP. A qualitative investigation into patients' views on visual field testing for Glaucoma monitoring. BMJ Open 2014;4:e003996
25. Prior M, Francis JJ, Azuara-Blanco A, et al; Glaucoma screening Platform Study group. Why do people present late with advanced Glaucoma? A qualitative interview study. Br J Ophthalmol 2013;97:1574-8
26. Lacey J, Cate H, Broadway DC. Barriers to adherence with Glaucoma medications: a qualitative research study. Eye 2009;23:924-32
27. Somner JE, Sii F, Bourne R, et al. What do patients with Glaucoma think about personal health records? Ophthalmic Physiol Opt 2013;33:627-33
28. Cross V, Shah P, Bativala R, et al. ReGAE 2: glaucoma awareness and the primary eye-care service: some perceptions among african caribbeans in Birmingham UK. Eye 2007;21:912-20
29. Cross V, Shah P, Glynn M, et al. ReGAE 5: can we improve the surgical journey for African-Caribbean patients undergoing Glaucoma filtration surgery? some preliminary findings. Clin Ophthalmol 2009;3:1-12
30. McCloud C, Lake S. Understanding the patient's lived experience of neovascular agerelated macular degeneration: a qualitative study. Eye 2015;29:1561-9
31. Vennedey V, Danner M, Evers SM, et al. Using qualitative research to facilitate the interpretation of quantitative results from a discrete choice experiment: insights from a survey in elderly ophthalmologic patients. Patient Prefer Adherence 2016;10:993-1002
32. Bennion AE, Shaw RL, Gibson JM. What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research. Soc Sci Med 2012;75:976-85
33. Lasch KE, Marquis P, Vigneux M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res 2010;19:1087-96
34. Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res 2009;18:1263-78
35. Bredart A, Marrel A, Abetz-Webb L, et al. Interviewing to develop Patient-Reported outcome (PRO) measures for clinical research: eliciting patients' experience. Health Qual Life Outcomes 2014;12:15
36. O'Cathain A, Thomas KJ, Drabble SJ, et al. What can qualitative research do for randomised controlled trials? A systematic mapping review. BMJ Open 2013;3:e002889
37. O'Cathain A, Thomas KJ, Drabble SJ, et al. Maximising the value of combining qualitative research and randomised controlled trials in health research: the QUAlitative research in trials (QUART) study-a mixed methods study. Health Technol Assess 2014;18:1-197
38. Gough D. Qualitative and mixed methods in systematic reviews. Syst Rev 2015;4:181
39. Curry LA, Nembhard IM, Bradley EH. Qualitative and mixed methods provide unique contributions to outcomes research. Circulation 2009;119:1442-52
40. Chan AW, Song F, Vickers A, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 2014;383:257-66
41. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998;317:1181-4
42. Denniston AK, Holland GN, Kidess A, et al. Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis. Orphanet J Rare Dis 2015;10:97
43. Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials 2012;13:132
44. Potter S, Brookes ST, Holcombe C, et al. Exploring methods the for selection and integration of stakeholder views in the development of core outcome sets: a case study in reconstructive breast surgery. Trials 2016;17:463
45. Ismail R, Azuara-Blanco A, Ramsay CR. Consensus on outcome measures for Glaucoma effectiveness trials: results from a delphi and nominal group technique approaches. J Glaucoma 2016;25:539-46
46. Denniston AK, Kyte D, Calvert M, et al. An introduction to patient-reported outcome measures in ophthalmic research. Eye 2014;28:637-45
47. Azuara-Blanco A, Burr J, Ramsay C, et al; EAGLE study group. Effectiveness of early Lens extraction for the treatment of primary angle-closure Glaucoma (EAGLE): a randomised controlled trial. Lancet 2016;388:1389-97
48. Brown DM, Kaiser PK, Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44
49. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31
50. Bressler NM, Chang TS, Suner IJ, et al. Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmol 2010;117:747-56
51. Suner IJ, Kokame GT, Yu E, et al. Responsiveness of NEI VFQ-25 to changes in visual acuity in Neovascular AMD: validation studies from two phase 3 clinical trials. Invest Ophthalmol Vis Sci 2009;50:3629-35
52. Chakravarthy U, Harding SP, Rogers CA, et al; IVAN Study Investigators. Ranibizumab versus Bevacizumab to treat neovascular age-related macular degeneration: oneyear findings from the IVAN randomized trial. Ophthalmology 2012;119:1399-411
53. Mitchell J, Wolffsohn J, Woodcock A, et al. The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness. Am J Ophthalmol 2008;146:447-54
54. Wren PA, Musch DC, Janz NK, et al; CIGTS Study Group. Contrasting the use of 2 vision-specific quality of life questionnaires in subjects with open-angle Glaucoma. J Glaucoma 2009;18:403-11
55. Leske MC, Heijl A, Hyman L, et al. Early manifest Glaucoma trial: design and baseline data. Ophthalmology 1999;106:2144-53
56. Peters D, Heijl A, Brenner L, et al. Visual impairment and vision-related quality of life in the early manifest Glaucoma trial after 20 years of follow-up. Acta Ophthalmol 2015;93:745-52
57. Quaranta L, Riva I, Gerardi C, et al. Quality of life in Glaucoma: a review of the literature. Adv Ther 2016;33:959-81
58. Mitchell P, Bandello F, Schmidt-Erfurth U, et al; RESTORE study group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-25
59. Lois N, Burr J, Norrie J, et al; Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group. Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci 2011;52:1586-92
60. Varma R, Bressler NM, Suner I, et al; BRAVO and CRUISE Study Groups. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology 2012;119:2108-18
61. Kempen JH, Altaweel MM, Holbrook JT, et al; Multicenter Uveitis Steroid Treatment Trial Research Group. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol 2010;149:550-61
62. Multicentre uveitis steroid treatment (MUST) Trial research group. Quality of life and risks associated with systemic Anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: fifty-four-month results of the multicenter uveitis steroid treatment trial and Followup study. Ophthalmol 2015;122:1976-86
63. Sugar EA, Holbrook JT, Kempen JH, et al; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology 2014;121:1855-62
64. Tadic V, Cooper A, Cumberland P, et al; Vision-related Quality of Life (VQoL) group. Measuring the quality of life of visually impaired children: first stage psychometric evaluation of the novel VQoL-CYP Instrument. PLoS One 2016;11:e0146225
65. Tadic V, Cooper A, Cumberland P, et al; Vision-related Quality of Life Group. Development of the functional vision questionnaire for children and young people with visual impairment: the FVQ-CYP. Ophthalmology 2013;120:2725-32
66. Tadic V, Cumberland PM, Lewando-Hundt G, et al; vision-related quality of life group. Do visually impaired children and their parents agree on the child's vision-related quality of life and functional vision? Br J Ophthalmol 2016 (Published Online First: 7 June 2016)
67. 36-item short form survey (SF-36). http://www. rand. org/health/surveys- tools/mos/36- item- short- form. html (accessed 5 Oct 2016)
68. EQ-5D, http://www. euroqol. org/about- eq- 5d. html (accessed 5 Oct 2016).
69. Black N. Patient reported outcome measures could help transform healthcare. BMJ 2013;346:f167
70. Patient reported outcome measures (PROMs). http://www. hscic. gov. uk/proms (accessed 16 Oct 2016)
71. Absolom K, Brown J, Blazeby J, et al. Real-time electronic patient outcome ReporTing of adverse events in UK Cancer trials (REPORT-UK). NCRI Conference 2013
72. Ashley L, Jones H, Forman D, et al. Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical Cancer registry data: the electronic Patient-reported outcomes from Cancer survivors (ePOCS) system. BMC Med Inform Decis Mak 2011;11:66
73. Gilbert A, Sebag-Montefiore D, Davidson S, et al. Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic. Gynecol Oncol 2015;136:429-39
74. Schandelmaier S, Conen K, von Elm E, et al; DISCO study group. Planning and reporting of quality-of-life outcomes in Cancer trials. Ann Oncol 2015;26:1966-73
75. Ahmed K, Kyte D, Keeley T, et al. Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK Cancer clinical trials: the EPiC study protocol. BMJ Open 2016;6:e012863
76. Kyte D, Draper H, Calvert M. Patient-reported outcome alerts: ethical and logistical considerations in clinical trials. Jama 2013;310:1229-30
77. PROQOLID. getting started with ePROVIDE. https://eprovide. mapi- trust. org (accessed
78. Consensus-based Standards for the selection of health Measurement Instruments. http://www. cosmin. nl (accessed 5 Oct 2016)
79. International Society for Quality of Life Research. http://www. isoqol. org (accessed 5 Oct 2016)
80. Gerstenblith AT, Thorne JE, Sobrin L, et al. Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 2007;114:1201-4
81. Koutroumanos N, Folkard A, Mattocks R, et al. Bringing together patient and specialists: the first birdshot day. Br J Ophthalmol 2013;97:648-52
82. National Institute for Health and Clinical Excellence. Ranibizumab and pegaptanib for age-related maculardegeneration. https://www. nice. org. uk/guidance/TA155/documents/macular- degeneration- agerelated- pegaptanib- and- ranibizumab- finalappraisal- determination3 (accessed 5 Oct 2016)
83. Somner JE, Sii F, Bourne RR, et al. Moving from PROMs to POEMs for Glaucoma care: a qualitative scoping exercise. Invest Ophthalmol Vis Sci 2012;53:5940-7
84. Cataracts. http://www. ichom. org/project/cataracts/(accessed 5 Oct 2016)
85. Macular degeneration. http://www. ichom. org/medical- conditions/maculardegeneration/(accessed 5 Oct 2016)
86. Heiligenhaus A, Foeldvari I, Edelsten C, et al. Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res 2012;64:1365-72
87. Douglas RS, Tsirbas A, Gordon M, et al; International Thyroid Eye Disease Society. Development of criteria for evaluating clinical response in thyroid eye disease using a modified delphi technique. Arch Ophthalmol 2009;127:1155-60